Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 2Terminated 1

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Pancreatic Neoplasms 1Melanoma 1Chronic Pain 1Breast Neoplasms 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1238Docetaxel 1227Oxaliplatin 1184Capecitabine 1178Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 640Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Gene Expression × Clear all
NCT05507034 2023-12-27

sCANsens

Universiteit Antwerpen

Unknown
150 enrolled
Breast

Breast Neoplasms, Chronic Pain

NCT05493878 2022-08-09

ITGA2b and SELP Expression in Cancer Pancreas and Biliary Tract Cancer

Assiut University

Unknown
128 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT02236546 2017-04-13

FDG-PET in Advanced Melanoma

Vanderbilt-Ingram Cancer Center

Phase NA Terminated
3 enrolled 4 charts
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡